Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CareDx Inc CDNA

Healthcare Biotechnology
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based... see more

Recent & Breaking News (NDAQ:CDNA)

CareDx Reports First Quarter 2023 Results

Business Wire May 10, 2023

CareDx to Report First Quarter 2023 Financial Results

Business Wire May 8, 2023

CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference

Business Wire April 25, 2023

CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation

Business Wire April 19, 2023

National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community

Business Wire April 6, 2023

CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation

GlobeNewswire April 5, 2023

CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association

Business Wire March 23, 2023

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

Business Wire March 10, 2023

The American Society of Transplant Surgeons Position Statement Supports Use of CareDx's AlloSure Kidney for Organ Transplant Surveillance

Business Wire March 7, 2023

CareDx Update Regarding Raymond James & Associates' Conference

Business Wire March 6, 2023

CareDx To Participate in the Raymond James & Associates' 44th Annual Institutional Investors Conference

Business Wire March 6, 2023

CareDx Comments on MolDX Publication of New Billing and Coding Article

Business Wire March 3, 2023

CareDx Key Supporter of the National Kidney Foundation's Annual Kidney Patient Summit

Business Wire March 1, 2023

CareDx Reports Fourth Quarter and Full Year 2022 Results

Business Wire February 27, 2023

CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

PR Newswire February 24, 2023

CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting

Business Wire February 22, 2023

CareDx to Report Fourth Quarter and Full Year 2022 Financial Results

Business Wire February 21, 2023

CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings

Business Wire February 16, 2023

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating CareDx, Inc.

Newsfile February 14, 2023

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

Business Wire February 13, 2023